Synthesis and evaluation of camphor and cytisine-based cyanopyrrolidines as DPP-IV inhibitors for the treatment of type 2 diabetes mellitus

S. O. Kuranov, I. P. Tsypysheva, M. V. Khvostov, Liana F. Zainullina, S. S. Borisevich, Yu V. Vakhitova, O. A. Luzina, N. F. Salakhutdinov

Результат исследования: Научные публикации в периодических изданияхстатья

9 Цитирования (Scopus)

Аннотация

In this study, bornyl- and cytisine-based cyanopyrrolidines as potent dipeptidyl peptidase-IV (DPP-IV) inhibitors were synthesised. The in vitro inhibiting activities of bornyl- and cytisine derivatives towards DPP-IV were evaluated. Bornyl-based cyanopyrrolidines were shown to have moderate inhibitory activity with regard to DPP-IV (1.27–15.78 µM). A docking study was performed to elucidate the structure-activity relationship of the obtained compounds. The in vivo hypoglycemic activities of the same compounds were evaluated with the oral glucose tolerance test (OGTT) in mice. Bornyl-based cyanopyrrolidines were shown to have good hypoglycemic activity.

Язык оригиналаанглийский
Страницы (с-по)4402-4409
Число страниц8
ЖурналBioorganic and Medicinal Chemistry
Том26
Номер выпуска15
DOI
СостояниеОпубликовано - 15 авг 2018

Fingerprint Подробные сведения о темах исследования «Synthesis and evaluation of camphor and cytisine-based cyanopyrrolidines as DPP-IV inhibitors for the treatment of type 2 diabetes mellitus». Вместе они формируют уникальный семантический отпечаток (fingerprint).

  • Цитировать